Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new site revision tag (Revision: v3.7.0) was added, while a large amount of ancillary text and metadata was removed, affecting navigation and background information but not the study's key data.SummaryDifference20%

- Check37 days agoChange DetectedA new Revision: v3.6.6 label was added, replacing Revision: v3.6.5, indicating a platform update without changes to the trial text or data.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision tag on the study page was updated from v3.6.4 to v3.6.5, indicating a minor publication/version update. This change does not modify study details, eligibility criteria, outcomes, or other user-facing content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous Revision: v3.6.3, which indicates a minor internal update to the page template or documentation.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2, updating the study record's version metadata.SummaryDifference0.0%

- Check102 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.2, indicating a new page build. This likely represents maintenance or a small fix to the study details page rather than a content update.SummaryDifference0.0%

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.